Examples of Sanofi Pharma in a sentence
This decentralised procedure concerns a generic application claiming essential similarity with the innovator product CoAprovel 300/25 mg and 150/12.5 mg tablets which have been registered through the centralised procedure by Sanofi Pharma Bristol-Myers Squibb SNC since 15 October 1998 (150/12.5 mg) and 28 August 2006 (300/25 mg).
All the notifications, complaints, requests, formal demands and other communications (hereinafter collectively referred to as the “Notifications”) shall be made in writing and shall be delivered in person, by hand, by registered letter, by mail with acknowledgement of receipt, to the Persons and addresses below: For the Company, at: Sanofi Pharma Bristol-Myers Squibb 54 La Boétie street 75008 Paris, France *CONFIDENTIAL TREATMENT REQUESTED.
This decentralised procedure concerns a generic application claiming essential similarity with the innovator product CoAprovel 300/12.5 mg tablets (EU License EU/1/98/086/016-022) which have been registered through the centralised procedure by Sanofi Pharma Bristol-Myers Squibb SNC since 15 October 1998.
This is indicated by the grand mean value of 4.17 which is included in the interval scale in the range of 3.41-4.20 in the high / good category.
The originator’s product Plavix® 75 mg film-coated tablets by Sanofi Pharma Bristol-Myers Squibb SNC were centrally registered on 15-07-1998 (EU/1/98/069).
The Partners have formed a general partnership Sanofi Pharma Bristol-Myers Squibb (the “ Company”).
The representatives of Sanofi shall be the persons serving from time to time as (i) President and Executive Director, Sanofi Pharma, (ii) Senior Vice President, Strategy, Sanofi Pharma and (iii) Vice President, Alliance Management, Sanofi Pharma.
Thus, generic medicinal products are claimed to be "essentially similar" to the reference medicinal products Plavix 75 mg film-coated tablet (Sanofi Pharma Bristol-Myers Squibb SNC).The film-coated tablets will be marketed in a dosage strengths of 75 milligrams (expressed to clopidogrel base) and packaged in OPA/Al/PVC//Al blisters and box.
The initial membership of Alliance Management shall consist of the two persons serving from time to time as Vice President, Alliance Management for each of BMS and Sanofi Pharma.
This decentralised procedure concerns a generic application claiming essential similarity with the innovator products Aprovel 75 mg, 150 mg and 300 mg film-coated tablets which have been registered through centralised procedure EU/1/97/046 by Sanofi Pharma Bristol-Myers Squibb SNC since 1997.